These results indicate that CLEC11A+ B cells may influence the osteosarcoma progression through modulating the tumour cells, osteoclasts or T cell sub‐cluster activities in osteosarcoma, and CLEC11A_B cells may act as novel therapeutic targets in the future. Here, CLEC11A is linked to neoplasm.